L Catterton’s first Chinese yuan fund named as lead investor in Trautec’s CNY200 million series B round
Chinese collagen tech start-up, Trautec Medical Technology has raised CNY200 million in a Series B funding round led by L Catterton’s first Chinese yuan fund and CLSA Asset Management.
CLICK HERE